Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rajakaruna

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Thorax|September 30, 2006
Cerebral tuberculomaP Dennison, G Rajakaruna
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2018
Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control studyJ Cannon, G Rajakaruna, J Dyer, et al.
The Lancet Regional Health. Southeast Asia|January 13, 2025
Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trialAnuja Premawardhena, Sakuni Wanasinghe, Chamodi Perera, et al.
BMJ Open|February 8, 2024
Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trialAnuja Premawardhena, Chamodi Perera, Muditha Nayana Wijethilaka, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Thorax|September 30, 2006
Cerebral tuberculomaP Dennison, G Rajakaruna
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2018
Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control studyJ Cannon, G Rajakaruna, J Dyer, et al.
The Lancet Regional Health. Southeast Asia|January 13, 2025
Deferoxamine, deferasirox, and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a randomised clinical trialAnuja Premawardhena, Sakuni Wanasinghe, Chamodi Perera, et al.
BMJ Open|February 8, 2024
Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trialAnuja Premawardhena, Chamodi Perera, Muditha Nayana Wijethilaka, et al.
Pageof 1